|
Monday, February 28 — 1:00 PM — Convention Center Room 200
Click on the numbers in parentheses to display abstracts.
Section G - PULMONARY
Chaired by: Kevin Leslie and Victor L. Roggli
| 1:00 |
DAX-1 and Androgen Receptor Expression in Diffuse Malignant Mesothelioma: Possible Targets of Hormonal Therapy
(1421)
TC Allen, A Sienko, DS Zander, N Singhal, DE Killen, A Haque, PT Cagle - University of Texas Health Center at Tyler, Tyler, TX; The Methodist Hospital, University of Texas Health Science Center at Houston Medical School, and Baylor College of Medicine, Houston, TX
|
| 1:15 |
Prolonged Survival in Malignant Mesothelioma: A Study of Sixteen Cases
(1487)
P Vergani, E Markert, L Burke, P Rolland, P Astoul, M Matrat, JC Pairon, P Brochard, A Gilg Soit Ilg, G Launoy, E Imbernon, M Goldberg, F Galateau-Salle - ERI3 INSERM, CHU CAEN, 14033 CAEN CEDEX, France; Cork University Hospital, Cork, Ireland; InVs, St. Maurice, Vincennes, France; INSERM, Creteil, France
|
| 1:30 |
Epidermal Growth Factor Receptor (EGFR) Gene Amplification in Pleural Malignant Mesothelioma (MM): A Chromogenic In Situ Hybridization (CISH) Assay
(1486)
MA Vasef, A Tafazzoli, K Sheibani - University of Iowa Hospitals and Clinics, Iowa City, IA; University of Southern California, Los Angeles, CA
|
| 1:45 |
Global Gene Expression Profiling of Epithelioid Mesotheliomas and Lung Adenocarcinomas for the Identification of New Differential Diagnostic Markers and the Development of a Microarray-Based Prediction Model
(1461)
F Lopez-Rios, J Szoke, S Hussain, S Chuai, AB Olshen, V Rusch, MF Zakowski, WL Gerald, M Ladanyi - Memorial Sloan-Kettering Cancer Center
|
| 2:00 |
Establishing 'Control' Standards to Aid the Diagnosis of Asbestosis; Asbestos Fibre Burden and Fibrosis in the Lungs of Non-Occupationally Exposed Persons
(1439)
AR Gibbs, FD Pooley, RL Attanoos - Cardiff and Wales NHS Trust, Penarth, South Glamorgan; University of Cardiff, Cardiff, South Glamorgan; Cardiff and Vale NHS Trust, Penarth, South Glamorgan, United Kingdom
|
| 2:15 |
Association of HHV8 (Human Herpesvirus 8) in Primary and Secondary Pulmonary Hypertension: An Immunohistochemical and PCR Study on Microdissected Tissue
(1451)
J Jagirdar, L Parmeswaram, IT Yeh, PT Cagle, D Zander, SM Yoo, SJ Gao - University of Texas Health Science Center, San Antonio, TX; The Methodist Hospital, Houston, TX; University of Texas Health Science Center, Houston, TX
|
| 2:30 |
The Lack of Expression of Human Herpesvirus 8 in Primary Pulmonary Hypertension
(1492)
BJ Yoder, B Yen-Lieberman, D Kohn, GW Procop, PE Pellett, SAA Comhair, W Xu, CF Farver - Cleveland Clinic Foundation, Cleveland, OH; Cleveland Clinic Foundation, Cleveland, OH
|
| 2:45 |
Pulmonary Veno-Occlusive Disease (PVOD) and Pulmonary Capillary Haemangiomatosis (PCH): A Study of 28 Cases
(1457)
S Lantuejoul, MN Sheppard, B Corrin, MM Burke, AG Nicholson - Royal Brompton and Harefield Hospital NHS Trust, London, United Kingdom
|
| 3:00 |
RECESS, EXHIBITS, POSTER SESSION II
|
| 4:30 |
NATHAN KAUFMAN TIMELY TOPICS LECTURE
Dr. Phillip A. Sharp
The Biological and Potentially Therapeutic Activities of Short RNAs
Convention Center, Ballroom B
|
|
|
